What Allbirds needs to do to make its Hail Mary AI pivot succeed

Allbirds' plan won't be easy to pull off. It needs more money, expertise, and relationships with hyperscalers.

Fake banknotes mocked a US president. And are now worth thousands.

This fake bank note lampoons the terrible banking policy under cheese-loving President Andrew Jackson and offers us a window ...

What Is A 1031 Exchange And How It Helps You Reinvest Without A Big Tax Hit

Discover how a 1031 exchange works to defer capital gains taxes on real estate. Learn the rules, timelines, and strategies to ...

Volato Group Suspends Further Utilization of Convertible Note Facility; Outstanding Note Balance Reduced to Zero

Volato Group, Inc. (NYSE American: SOAR) ("Volato" or the "Company") today announced that it has suspended further borrowings/drawdowns under its convertible note facility (the "Facility"). The ...

Revolution Medicines, Inc. Announces Proposed Offerings of Common Stock and Convertible Senior Notes

Revolution Medicines intends to use the net proceeds from the common stock offering and the note offering for general corporate purposes, including research and development expenses, expenses relating ...
Guessing Headlights on MSNOpinion

Clarkson used Maserati to explain why Italy kept its icons

In a review of the Maserati MCPura Cielo, Jeremy Clarkson argues Britain treated car brands as disposable industry, while ...
TMCnet

Socket Mobile Announces $0.5 Million Secured Subordinated Convertible Note Financing

FREMONT, Calif., March 30, 2026 /PRNewswire/ -- Socket Mobile, Inc. (NASDAQ: SCKT), a leading provider of data capture and delivery solutions for enhanced productivity, today announced completion of a ...
MarketWatch

Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million

The MarketWatch News Department was not involved in the creation of this content. WALTHAM, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. ("Zenas," "Zenas BioPharma" or the "Company") ...
Business Insider

Zenas BioPharma Announces Pricing of Concurrent Public Offerings of 2.50% Convertible Senior Notes Due 2032 and Common Stock with Aggregate Gross Proceeds of $300.0 Million

WALTHAM, Mass., March 27, 2026 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to ...
BioSpace

Zenas BioPharma Announces Proposed Concurrent Public Offerings of Convertible Senior Notes Due 2032 and Common Stock

WALTHAM, Mass., March 26, 2026 (GLOBE NEWSWIRE)-- Zenas BioPharma, Inc. (“Zenas,” “Zenas BioPharma” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to ...